Evogene's First Quarter 2014 Earnings Announcement Schedule
Business Wire - Thu Apr 17, 6:00AM CDT
Evogene Ltd. (NYSE, TASE:EVGN), a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, announced today that it will release its financial results for the first quarter of 2014 on Wednesday, May 7, 2014.
Evogene Announces Filing of 2013 Annual Report
Business Wire - Tue Apr 08, 7:08AM CDT
Evogene Ltd. (NYSE:EVGN)(TASE:EVGN), a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, today announced that it has filed its annual report containing audited consolidated financial statements for the year ended December 31, 2013 with the United States Securities and Exchange Commission, on Form 20-F.
Evogene Subsidiary and SLC Agricola Sign Collaboration Agreement for Commercial Production of Castor Bean in Brazil
Business Wire - Tue Mar 25, 6:05AM CDT
Evogene Ltd. (NYSE, TASE:EVGN), a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, and SLC Agricola S.A. (Bovespa: SLCE3; ADR's: SLCJY; Bloomberg: SLCE3:BZ; Reuters: SLCE3.SA), one of Brazil's largest landowners and agriculture businesses, announced today the signing of a collaboration agreement between SLC and Evofuel Ltd., Evogene's wholly-owned subsidiary, for the commercial production of Evofuel developed castor bean varieties in Brazil, expected to take place during 2016. Evofuel focuses on the development of high yielding castor bean seeds as a second-generation feedstock for the growing biofuel and other industrial markets.
Outbrain Appoints Ziv Kop As COO
PR Newswire - Fri Mar 21, 12:30PM CDT
Outbrain, the leading content discovery platform, today announced that Ziv Kop, founding member of Outbrain's Board of Directors and former Managing Partner at GlenRock Israel, has joined the company as Chief Operating Officer.
Evogene Reports Fourth Quarter and Year-End 2013 Financial Results
Business Wire - Wed Mar 19, 6:05AM CDT
--Extension and expansion of key collaboration agreements with Monsanto, Syngenta and DuPont-Pioneer
Evogene Enhances Predictive Gene Stacking Capabilities
Business Wire - Thu Mar 06, 7:53AM CST
Evogene Ltd. (NYSE:EVGN) (TASE:EVGN), a leading plant genomics company specializing in improving crop productivity for the food, feed and biofuel industries, announced today enhanced capabilities for gene stacking prediction with the introduction of PlaNet (Plant Networks) version 2.0 computational platform. The upgraded version includes more than doubling of the platform's interaction data sources and types, and improved algorithms for data analysis.
Evogene's Fourth Quarter and Full Year 2013 Earnings Announcement Schedule
Business Wire - Thu Feb 27, 6:02AM CST
Evogene Ltd. (NYSE:EVGN)(TASE:EVGN), a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, announced today that it will release its fourth quarter and full year 2013 financial results on Wednesday, March 19, 2014.
Evogene Launches Target Discovery Platform for Novel Herbicides
Business Wire - Tue Feb 11, 6:00AM CST
Evogene Ltd. (NYSE: EVGN) (TASE: EVGN), a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, announced today a key milestone in its discovery program for novel chemical herbicides with the launch of PoinTar, a computationally based target discovery platform for novel herbicides. Targets are key molecules, responsible for essential biological processes in weeds, which have the potential to be chemically inhibited to cause weed death.
Evogene declares close of its IPO in US and underwriters full exercise of option
M2 - Wed Nov 27, 6:14AM CST
Evogene Ltd (NYSE:EVGN) (TASE:EVGN), a plant genomics company, said on Tuesday that it closed its initial public offering (IPO) of 5,750,000 ordinary shares at USD14.75 per share in the US, including the full exercise of the underwriters' option to buy up to 750,000 additional ordinary shares.
Evogene Ltd concludes IPO of 5.75m ordinary shares, including over-allotment option
M2 - Wed Nov 27, 3:23AM CST
Plant genomics company Evogene Ltd (NYSE:EVGN) (Tel Aviv:EVGN.TA) reported on Tuesday the completion of an initial public offering of 5,750,000 ordinary shares in the US.
Evogene Announces Closing of its Initial Public Offering in the United States and Full-Exercise of Over-Allotment Option
Business Wire - Tue Nov 26, 12:55PM CST
Evogene Ltd. (NYSE: EVGN) (TASE: EVGN), a plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, announced today the closing of its previously announced initial public offering in the United States of 5,750,000 ordinary shares at the price to the public of $14.75 per share, which includes the exercise in full by the underwriters of their option to purchase up to 750,000 additional ordinary shares. All of the shares in the offering were offered by Evogene.